Seroprevalence of severe acute respiratory coronavirus virus 2 (SARS-CoV-2) antibodies by risk of exposure in a community health system

Infect Control Hosp Epidemiol. 2022 Mar;43(3):407-409. doi: 10.1017/ice.2020.1438. Epub 2021 Jan 11.

Authors

Jeffrey J Fletcher^{1

2}, Eric C Feucht¹, Peter Y Hahn¹, Theresa N McGoff³, Del J Dehart⁴, Mohamad E El Mortada⁴, Ronald G Grifka³

Affiliations

¹ Metro Health University of Michigan Health, Critical Care Medicine, Wyoming, Michigan.
² Department of Neurosurgery, University of Michigan Medical School, Ann Arbor, Michigan.
³ Metro Health University of Michigan Health, Department of Research, Wyoming, Michigan.
⁴ Metro Health University of Michigan Health, Infectious Disease, Wyoming, Michigan.

No abstract available

MeSH terms

Antibodies, Viral
COVID-19* / epidemiology
Community Health Planning
Humans
SARS-CoV-2*
Seroepidemiologic Studies

Substances

Antibodies, Viral